Friday, February 01, 2013 10:31:48 AM
B) NOTHING SAID ON THIS BOARD WILL HAVE A SIGNIFICANT EFFECT ON SHARE PRICE.
C) Only commercialization will raise the PPS to the levels we all hope it hits.
D) The science here is sound. Listen to ZF or others with scientific knowledge when it comes to that end. Ignore those without the background knowledge unless they back up their claim with some evidence, because you can easily be led astray.
E) The board needs more business experts. It's more than just selling some silk. I think most realize that but it would be nice to have some more business type discussions.
I'm crazy positive on KBLB, especially because of what I've directly read about their science. I hope the business end holds up, but realize that our potential is hard to map. Who will team up with us? Buyout? Supplier? Patents? Lots of people have thoughts but I think they get rolled around so much on the board people just think they're facts. A conference call would be nice after the next big PR to allow us the opportunity to hear the story in a narrative sense, rather than through discrete PRs.
There's so much conjecture here that it's becoming difficult to weed through the bull to get to good questions. Everyone's so busy throwing out crazy claims, and discounting the crazy claim from someone else.
It used to be a productive place to ask questions and get answers, but the same factors that chased ZF away are pushing others away too. Balance doesn't mean insanely positive and insanely negative people talking over each other. Critical does not mean bad. It's about finding out if the company you've invested in is doing what you're comfortable investing in. I don't think the board is giving that information anymore, and it's likely correlated with the turnover of active posters.
Recent KBLB News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:30:40 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 11/05/2024 12:00:04 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM